Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Research Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (688336.SS) on Bullrun: market cap CNY 29.39B, P/E 9.5, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker688336.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCNY
- Market capCNY 29.39B
- P/E9.5
- Dividend yield1.4%
- Financial periodQ2 2026
- RevenueCNY 434.47M
- Net incomeCNY 193.21M
- Free cash flowCNY 29.99M
- Gross margin80.3%
Valuation Snapshot
latest market cap is CNY 29.39B; P/E is 9.5; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 9.53x versus a Healthcare sector median of 21.8x (56.3% below).
Latest dividend yield is 1.37% versus a Healthcare sector median of 2.4% (42.9% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 29.39B | 9.5 | 1.5% | 0.49 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.49 CNY, yield 1.4%.
About Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include Enbrel, a recombinant human type II tumor necrosis factor receptor-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation;
ETFs that hold Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
US-listed ETFs
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. is held by 11 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | 0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) | 0.01% | 0.58% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s market cap?
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s market capitalization is CNY 29.39B.
What is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s P/E ratio?
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s price-to-earnings (P/E) ratio is 9.5.
Does Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. pay a dividend?
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has a dividend yield of 1.4%.
What does Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. do?
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.